S&P 500   4,554.89
DOW   35,416.98
QQQ   390.19
Alibaba is down more than 10% since earnings, now what?
Secure your stake in the Smart Home industry. (Ad)
5 stocks for the Christmas wishlist: Hoping for a pullback
Teva Pharma is the way to play the re-rise of generic drugs
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Lemonade nears breakout, short interest surges, analysts bearish
ULTA stock is setting up to swing for the fences
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Get ready for Christmas shopping-sprees with these 2 winners
Li Auto smashes estimates proving EVs can be profitable
S&P 500   4,554.89
DOW   35,416.98
QQQ   390.19
Alibaba is down more than 10% since earnings, now what?
Secure your stake in the Smart Home industry. (Ad)
5 stocks for the Christmas wishlist: Hoping for a pullback
Teva Pharma is the way to play the re-rise of generic drugs
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Lemonade nears breakout, short interest surges, analysts bearish
ULTA stock is setting up to swing for the fences
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Get ready for Christmas shopping-sprees with these 2 winners
Li Auto smashes estimates proving EVs can be profitable
S&P 500   4,554.89
DOW   35,416.98
QQQ   390.19
Alibaba is down more than 10% since earnings, now what?
Secure your stake in the Smart Home industry. (Ad)
5 stocks for the Christmas wishlist: Hoping for a pullback
Teva Pharma is the way to play the re-rise of generic drugs
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Lemonade nears breakout, short interest surges, analysts bearish
ULTA stock is setting up to swing for the fences
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Get ready for Christmas shopping-sprees with these 2 winners
Li Auto smashes estimates proving EVs can be profitable
S&P 500   4,554.89
DOW   35,416.98
QQQ   390.19
Alibaba is down more than 10% since earnings, now what?
Secure your stake in the Smart Home industry. (Ad)
5 stocks for the Christmas wishlist: Hoping for a pullback
Teva Pharma is the way to play the re-rise of generic drugs
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Lemonade nears breakout, short interest surges, analysts bearish
ULTA stock is setting up to swing for the fences
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Get ready for Christmas shopping-sprees with these 2 winners
Li Auto smashes estimates proving EVs can be profitable

HealthEquity Stock Price, News & Analysis (NASDAQ:HQY)

$66.85
-0.27 (-0.40%)
(As of 11/28/2023 ET)
Compare
Today's Range
$66.27
$67.43
50-Day Range
$64.14
$76.13
52-Week Range
$48.86
$76.62
Volume
516,903 shs
Average Volume
654,221 shs
Market Capitalization
$5.72 billion
P/E Ratio
445.67
Dividend Yield
N/A
Price Target
$84.14

HealthEquity MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
25.9% Upside
$84.14 Price Target
Short Interest
Healthy
3.82% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.63mentions of HealthEquity in the last 14 days
Based on 4 Articles This Week
Insider Trading
Selling Shares
$4.62 M Sold Last Quarter
Proj. Earnings Growth
40.00%
From $1.35 to $1.89 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.48 out of 5 stars

Medical Sector

186th out of 949 stocks

Health Information Services Industry

2nd out of 7 stocks


HQY stock logo

About HealthEquity Stock (NASDAQ:HQY)

HealthEquity, Inc. provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts. It also provides mutual fund investment platform; and online-only automated investment advisory services through Advisor, a Web-based tool. In addition, the company offers flexible spending accounts; health reimbursement arrangements; and Consolidated Omnibus Budget Reconciliation Act continuation services, as well as administers pre-tax commuter benefit programs. It serves clients through a direct sales force; benefits brokers and advisors; and a network of health plans, benefits administrators, benefits brokers and consultants, and retirement plan record-keepers. HealthEquity, Inc. was incorporated in 2002 and is headquartered in Draper, Utah.

HQY Stock Price History

HQY Stock News Headlines

HealthEquity (HQY) Set to Announce Quarterly Earnings on Tuesday
HealthEquity Inc HQY
Secure your stake in the Smart Home industry.
Last chance to invest in RYSE – the shade automation technology launching in over 100 Best Buy stores this month.
Healthequity Inc
HealthEquity Named Top Workplace in Rankings Nationwide
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity
Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
Baird Upgrades Healthequity (HQY)
Barrington Keeps Their Buy Rating on Healthequity (HQY)
Here's Why HealthEquity (HQY) is a Strong Growth Stock
Company News for Sep 7, 2023
See More Headlines
Receive HQY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for HealthEquity and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
9/05/2023
Today
11/28/2023
Next Earnings (Confirmed)
12/05/2023
Fiscal Year End
1/31/2024

Industry, Sector and Symbol

Industry
Health Information Services
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:HQY
Employees
3,170
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$84.14
High Stock Price Target
$94.00
Low Stock Price Target
$72.00
Potential Upside/Downside
+25.9%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
7 Analysts

Profitability

Net Income
$-26,140,000.00
Pretax Margin
1.93%

Debt

Sales & Book Value

Annual Sales
$937.91 million
Cash Flow
$2.65 per share
Book Value
$22.40 per share

Miscellaneous

Free Float
83,289,000
Market Cap
$5.72 billion
Optionable
Optionable
Beta
0.77
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report














HQY Stock Analysis - Frequently Asked Questions

Should I buy or sell HealthEquity stock right now?

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for HealthEquity in the last twelve months. There are currently 7 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" HQY shares.
View HQY analyst ratings
or view top-rated stocks.

What is HealthEquity's stock price target for 2024?

7 Wall Street analysts have issued 1 year price targets for HealthEquity's shares. Their HQY share price targets range from $72.00 to $94.00. On average, they expect the company's stock price to reach $84.14 in the next year. This suggests a possible upside of 25.9% from the stock's current price.
View analysts price targets for HQY
or view top-rated stocks among Wall Street analysts.

How have HQY shares performed in 2023?

HealthEquity's stock was trading at $61.64 at the beginning of the year. Since then, HQY stock has increased by 8.5% and is now trading at $66.85.
View the best growth stocks for 2023 here
.

When is HealthEquity's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, December 5th 2023.
View our HQY earnings forecast
.

How can I listen to HealthEquity's earnings call?

HealthEquity will be holding an earnings conference call on Tuesday, December 5th at 4:30 PM Eastern. Interested parties can register for or listen to the call using this link.

How were HealthEquity's earnings last quarter?

HealthEquity, Inc. (NASDAQ:HQY) issued its quarterly earnings results on Tuesday, September, 5th. The company reported $0.34 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.28 by $0.06. The firm had revenue of $243.55 million for the quarter, compared to analyst estimates of $238.89 million. HealthEquity had a net margin of 1.37% and a trailing twelve-month return on equity of 5.08%.

What guidance has HealthEquity issued on next quarter's earnings?

HealthEquity updated its FY24 earnings guidance on Tuesday, September, 5th. The company provided earnings per share guidance of $1.97-$2.06 for the period, compared to the consensus EPS estimate of $1.93. The company issued revenue guidance of $980-$990 million, compared to the consensus revenue estimate of $981.09 million.

What is Jon Kessler's approval rating as HealthEquity's CEO?

359 employees have rated HealthEquity Chief Executive Officer Jon Kessler on Glassdoor.com. Jon Kessler has an approval rating of 95% among the company's employees. This puts Jon Kessler in the top 30% of approval ratings compared to other CEOs of publicly-traded companies. 69.0% of employees surveyed would recommend working at HealthEquity to a friend.

What other stocks do shareholders of HealthEquity own?

Based on aggregate information from My MarketBeat watchlists, some companies that other HealthEquity investors own include NVIDIA (NVDA), Shopify (SHOP), Block (SQ), Okta (OKTA), PayPal (PYPL), Twilio (TWLO), Trade Desk (TTD), Alibaba Group (BABA), Casino, Guichard-Perrachon Societe Anonyme (COP) and Input Capital (INP).

Who are HealthEquity's major shareholders?

HealthEquity's stock is owned by many different retail and institutional investors. Top institutional investors include FMR LLC (6.60%), William Blair Investment Management LLC (3.09%), JPMorgan Chase & Co. (2.72%), Clearbridge Investments LLC (2.58%), Brown Advisory Inc. (2.42%) and Allspring Global Investments Holdings LLC (1.57%). Insiders that own company stock include Adrian T Dillon, Angelique Christine Hill, Darcy G Mott, Darcy G Mott, Debra Charlotte Mccowan, Delano Ladd, Edward Bloomberg, Elimelech Rosner, Frank Corvino, Gayle Furgurson Wellborn, Ian Sacks, Jon Kessler, Larry L Trittschuh, Stuart B Parker, Tyson D Murdock and William Robert Otten.
View institutional ownership trends
.

How do I buy shares of HealthEquity?

Shares of HQY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (NASDAQ:HQY) was last updated on 11/29/2023 by MarketBeat.com Staff

My Account -